Compare AVTX & MFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AVTX | MFM |
|---|---|---|
| Founded | 2011 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 248.3M | 222.4M |
| IPO Year | 2015 | N/A |
| Metric | AVTX | MFM |
|---|---|---|
| Price | $17.11 | $5.42 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $32.29 | N/A |
| AVG Volume (30 Days) | ★ 302.8K | 108.1K |
| Earning Date | 11-06-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 4.08% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.03 |
| Revenue | ★ $192,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $176.67 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.39 | $4.37 |
| 52 Week High | $20.72 | $5.48 |
| Indicator | AVTX | MFM |
|---|---|---|
| Relative Strength Index (RSI) | 48.21 | 53.31 |
| Support Level | $15.49 | $5.35 |
| Resistance Level | $18.54 | $5.43 |
| Average True Range (ATR) | 1.17 | 0.06 |
| MACD | -0.28 | 0.00 |
| Stochastic Oscillator | 44.93 | 79.55 |
Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).
MFS Municipal Income Trust is a diversified closed-end management investment company. Its investment objective is to seek high current income exempt from federal income tax, but may also consider capital appreciation. The fund invests a majority of its net assets, including assets attributable to preferred shares and borrowings for investment purposes, in municipal bonds.